Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 106(15): 6220-5, 2009 Apr 14.
Article in English | MEDLINE | ID: mdl-19339494

ABSTRACT

Facioscapulohumeral muscular dystrophy (FSHD) is a progressive muscle disorder that has been associated with a contraction of 3.3-kb repeats on chromosome 4q35. FSHD is characterized by a wide clinical inter- and intrafamilial variability, ranging from wheelchair-bound patients to asymptomatic carriers. Our study is unique in comparing the gene expression profiles from related affected, asymptomatic carrier, and control individuals. Our results suggest that the expression of genes on chromosome 4q is altered in affected and asymptomatic individuals. Remarkably, the changes seen in asymptomatic samples are largely in products of genes encoding several chemokines, whereas the changes seen in affected samples are largely in genes governing the synthesis of GPI-linked proteins and histone acetylation. Besides this, the affected patient and related asymptomatic carrier share the 4qA161 haplotype. Thus, these polymorphisms by themselves do not explain the pathogenicity of the contracted allele. Interestingly, our results also suggest that the miRNAs might mediate the regulatory network in FSHD. Together, our results support the previous evidence that FSHD may be caused by transcriptional dysregulation of multiple genes, in cis and in trans, and suggest some factors potentially important for FSHD pathogenesis. The study of the gene expression profiles from asymptomatic carriers and related affected patients is a unique approach to try to enhance our understanding of the missing link between the contraction in D4Z4 repeats and muscle disease, while minimizing the effects of differences resulting from genetic background.


Subject(s)
Gene Expression Regulation/genetics , Heterozygote , Muscular Dystrophy, Facioscapulohumeral/genetics , Transcription, Genetic/genetics , Case-Control Studies , Chromosomes, Human, Pair 4/genetics , Gene Expression Profiling , Humans , Polymorphism, Genetic/genetics
2.
Eur J Hum Genet ; 15(12): 1276-9, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17895902

ABSTRACT

SPG4 mutations are the most frequent cause of autosomal-dominant hereditary spastic paraplegia (HSP). SPG4 HSP is characterized by large inter- and intrafamilial variability in age at onset (AAO) and disease severity. The broad spectrum of SPG4 mutations has recently been further extended by the finding of large genomic deletions in SPG4-linked pedigrees negative for 'small' mutations. We had previously reported a very large pedigree, linked to the SPG4 locus with many affected members, which showed gender difference in clinical manifestation. Screening for copy number aberrations revealed the first case of a multi-exonic duplication (exon10_12dup) in the SPG4 gene. The mutation leads to a premature stop codon, suggesting that the protein product is not functional. The analysis of 30 individuals who carry the mutation showed that males have on average an earlier AAO and are more severely affected. The present family suggests that this HSP pathogenesis may be modulated by factors related to individual background and gender as observed for other autosomal dominant conditions, such as facio-scapulohumeral muscular dystrophy or amyloidosis. Understanding why some individuals, particularly women, are 'partially protected' from the effects of this and other pathogenic mutations is of utmost importance.


Subject(s)
Adenosine Triphosphatases/genetics , Exons/genetics , Gene Duplication , Pedigree , Penetrance , Sex Characteristics , Spastic Paraplegia, Hereditary/genetics , Adolescent , Adult , Brazil , Female , Heterozygote , Humans , Infant , Kaplan-Meier Estimate , Male , Middle Aged , Mutation/genetics , Spastin
3.
Hum Genet ; 119(1-2): 23-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16341710

ABSTRACT

Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) is associated with contractions of D4Z4 repeat on 4q35. It displays a remarkable inter- and intra-familial clinical variability ranging from severe phenotype to asymptomatic carriers. Mosaicism for the contracted FSHD-sized allele is a recurrent finding, but only DNA from lymphocytes had been studied. It is currently not known if mosaicism is unequally distributed between different tissues and if muscle is relatively spared for the presence of the disease allele in mosaic asymptomatic carriers of a disease allele. Here we compare DNA extracted from peripheral blood lymphocytes (PBL), fibroblasts and muscle from a mosaic asymptomatic female carrier and mother of a FSHD patient. PFGE analysis showed a complex allelic segregation: two independent mitotic rearrangement episodes occurred, resulting in mosaicism for a contracted D4Z4 repeat on 4q35 in the mother and mosaicism for an expanded D4Z4 repeat on 10q26 in the affected daughter. The results show that the proportion of mosaicism in PBL and muscle were comparable, while in fibroblasts there was some variation in the mosaicism, which might be caused by culturing artefacts. This finding supports the hypothesis that a mitotic contraction of D4Z4 is an early embryonic event and indicates that the degree of mosaicism in PBL is representative for that of muscle.


Subject(s)
Mosaicism , Muscular Dystrophy, Facioscapulohumeral/pathology , Repetitive Sequences, Nucleic Acid/genetics , Alleles , Chromosomes, Human, Pair 4 , DNA/genetics , DNA/metabolism , Deoxyribonuclease EcoRI/metabolism , Deoxyribonuclease HindIII/metabolism , Electrophoresis, Gel, Pulsed-Field , Family Health , Female , Fibroblasts/metabolism , Heterozygote , Humans , Male , Middle Aged , Muscles/metabolism , Muscular Dystrophy, Facioscapulohumeral/blood , Muscular Dystrophy, Facioscapulohumeral/genetics , Pedigree
SELECTION OF CITATIONS
SEARCH DETAIL
...